BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coluzzi F, Scerpa MS, Pergolizzi J. Naldemedine: A New Option for OIBD. J Pain Res 2020;13:1209-22. [PMID: 32547183 DOI: 10.2147/JPR.S243435] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Coluzzi F, Caputi FF, Billeci D, Pastore AL, Candeletti S, Rocco M, Romualdi P. Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists. Ther Clin Risk Manag 2020;16:821-37. [PMID: 32982255 DOI: 10.2147/TCRM.S262843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Takata K, Nakazawa M, Honda K, Hashimoto S. Post-marketing surveillance of the safety and effectiveness of naldemedine in the management of opioid-induced constipation in patients with cancer pain in Japan. Support Care Cancer 2022. [PMID: 35044484 DOI: 10.1007/s00520-022-06807-y] [Reference Citation Analysis]
3 Ishida M, Uchida N, Yabuno A, Hasegawa K, Mizunuma N, Takahashi T, Onishi H. Opioid withdrawal syndrome developing after long-term administration of naldemedine. Palliat Support Care 2022;:1-3. [PMID: 35543119 DOI: 10.1017/S147895152200044X] [Reference Citation Analysis]
4 Abel R, Paredes Ramos M, Chen Q, Pérez-sánchez H, Coluzzi F, Rocco M, Marchetti P, Mura C, Simmaco M, Bourne PE, Preissner R, Banerjee P. Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2. Front Chem 2020;8:590263. [DOI: 10.3389/fchem.2020.590263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
5 Ishida M, Hiraoka M, Yaguchi A, Sugano K, Adachi N, Itoga T, Ishiguro T, Onishi H. Naldemedine-induced opioid withdrawal syndrome with severe psychiatric symptoms in an advanced cervical cancer patient without brain metastasis. Palliat Support Care 2021;:1-3. [PMID: 34955117 DOI: 10.1017/S1478951521001917] [Reference Citation Analysis]
6 BouSaba J, Sannaa W, Camilleri M. Update on the role of naldemedine in opioid-induced constipation in patients with chronic noncancer pain. Therap Adv Gastroenterol 2022;15:17562848221078638. [PMID: 35509419 DOI: 10.1177/17562848221078638] [Reference Citation Analysis]
7 Coluzzi F, Alvaro D, Caraceni AT, Gianni W, Marinangeli F, Massazza G, Pinto C, Varrassi G, Lugoboni F. Common Clinical Practice for Opioid-Induced Constipation: A Physician Survey. J Pain Res 2021;14:2255-64. [PMID: 34335054 DOI: 10.2147/JPR.S318564] [Reference Citation Analysis]
8 Alvaro D, Caraceni AT, Coluzzi F, Gianni W, Lugoboni F, Marinangeli F, Massazza G, Pinto C, Varrassi G. What to Do and What Not to Do in the Management of Opioid-Induced Constipation: A Choosing Wisely Report. Pain Ther 2020;9:657-67. [PMID: 32940898 DOI: 10.1007/s40122-020-00195-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]